Intrinsic Value of S&P & Nasdaq Contact Us

Tempest Therapeutics, Inc. TPST NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — TPST

Tempest Therapeutics, Inc. (TPST) has a market capitalization of $9.99M and trades at $2.25. The 52-week range is 1.5-12.23.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-6.33.

The stock has a beta of -2.39, operates in the Healthcare sector.

Trading Data
Current Price$2.25
52-Week Range1.5-12.23
Volume306.42K
Avg Volume (30D)186.41K
Market Cap$9.99M
Beta (1Y)-2.39
Company
IPO Date2012-11-12
Employees24
CEOMatthew Angel
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS87978U2078
CUSIP87978U207
Income (Latest Year)
EBITDA$-25.79M
Operating Income$-26.58M
Net Income$-26.26M
EPS$-6.33
EPS Diluted$-6.33
Shares Outstanding$4.15M
Balance Sheet (Latest Year)
Total Assets$16.93M
Current Assets$8.27M
Cash & ST Investments$7.71M
Total Liabilities$10.26M
Total Debt$8.14M
Net Debt$434K
Total Equity$6.67M
Debt / Equity1.22
Valuation Ratios
P/E Ratio-0.4
P/B Ratio1.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message